Oxford BioMedica PLC
LSE:OXB

Watchlist Manager
Oxford BioMedica PLC Logo
Oxford BioMedica PLC
LSE:OXB
Watchlist
Price: 412.5 GBX -1.43% Market Closed
Market Cap: 434.6m GBX
Have any thoughts about
Oxford BioMedica PLC?
Write Note

Oxford BioMedica PLC
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Oxford BioMedica PLC
PP&E Net Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Oxford BioMedica PLC
LSE:OXB
PP&E Net
ÂŁ71.6m
CAGR 3-Years
1%
CAGR 5-Years
7%
CAGR 10-Years
34%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
PP&E Net
$13m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
PP&E Net
$95.7m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
PP&E Net
$20.6m
CAGR 3-Years
53%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
PP&E Net
ÂŁ42.7m
CAGR 3-Years
5%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
PP&E Net
ÂŁ479.4m
CAGR 3-Years
6%
CAGR 5-Years
5%
CAGR 10-Years
7%

See Also

What is Oxford BioMedica PLC's PP&E Net?
PP&E Net
71.6m GBP

Based on the financial report for Jun 30, 2024, Oxford BioMedica PLC's PP&E Net amounts to 71.6m GBP.

What is Oxford BioMedica PLC's PP&E Net growth rate?
PP&E Net CAGR 10Y
34%

Over the last year, the PP&E Net growth was -41%. The average annual PP&E Net growth rates for Oxford BioMedica PLC have been 1% over the past three years , 7% over the past five years , and 34% over the past ten years .

Back to Top